DE602004026499D1 - Topisch applizierbare kosmetische oder pharmazeutische Zusammensetzung zur Prävention oder Behandlung androgener Alopezie - Google Patents

Topisch applizierbare kosmetische oder pharmazeutische Zusammensetzung zur Prävention oder Behandlung androgener Alopezie

Info

Publication number
DE602004026499D1
DE602004026499D1 DE602004026499T DE602004026499T DE602004026499D1 DE 602004026499 D1 DE602004026499 D1 DE 602004026499D1 DE 602004026499 T DE602004026499 T DE 602004026499T DE 602004026499 T DE602004026499 T DE 602004026499T DE 602004026499 D1 DE602004026499 D1 DE 602004026499D1
Authority
DE
Germany
Prior art keywords
pharmaceutical composition
prevention
treatment
androgenic alopecia
topically administrable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE602004026499T
Other languages
English (en)
Inventor
Ugo Raffaello Citernesi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Farmaka Srl
Original Assignee
Farmaka Srl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Farmaka Srl filed Critical Farmaka Srl
Publication of DE602004026499D1 publication Critical patent/DE602004026499D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60—Sugars; Derivatives thereof
    • A61K8/606—Nucleosides; Nucleotides; Nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A61K8/66—Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00—Preparations for affecting hair growth

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE602004026499T 2003-02-28 2004-01-20 Topisch applizierbare kosmetische oder pharmazeutische Zusammensetzung zur Prävention oder Behandlung androgener Alopezie Expired - Lifetime DE602004026499D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT000369A ITMI20030369A1 (it) 2003-02-28 2003-02-28 Composizione cosmetica o farmaceutica ad uso topico per impedire o contrastare l'alopecia androgenetica.

Publications (1)

Publication Number Publication Date
DE602004026499D1 true DE602004026499D1 (de) 2010-05-27

Family

ID=32800694

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004026499T Expired - Lifetime DE602004026499D1 (de) 2003-02-28 2004-01-20 Topisch applizierbare kosmetische oder pharmazeutische Zusammensetzung zur Prävention oder Behandlung androgener Alopezie

Country Status (6)

Country Link
US (1) US6953571B2 (de)
EP (1) EP1454633B1 (de)
AT (1) ATE464063T1 (de)
DE (1) DE602004026499D1 (de)
ES (1) ES2341855T3 (de)
IT (1) ITMI20030369A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1849481A4 (de) * 2005-01-07 2012-11-28 Rohto Pharma Zusammensetzung zur topischen anwendung
US20170266218A1 (en) * 2016-03-21 2017-09-21 Steve McNerlin Nad+ coenzyme formulation and methods of making and using the same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5514672A (en) * 1981-02-17 1996-05-07 Bazzano; Gail S. Use of retinoids and compositions containing same for hair growth
US4684635A (en) * 1984-05-11 1987-08-04 Norman Orentreich Compositions and methods for inhibiting the action of androgens
JPS6212721A (ja) 1985-07-10 1987-01-21 Yasahiro Morita 椎茸霊芝の製造法
DE69032648T2 (de) * 1989-07-07 1999-04-08 Endorecherche Inc., Ste-Foy, Quebec Androgenderivate zur Hemming der Aktivität der Sexualsteroide
US6733776B1 (en) * 1992-04-02 2004-05-11 Anticancer, Inc. Method for promoting hair growth
US5422371A (en) * 1992-05-27 1995-06-06 Arch Development Corp. Methods and compositions for inhibiting 5α-reductase activity
FR2732597B1 (fr) 1995-04-05 1997-05-16 Oreal Utilisation dans une composition en tant qu'activateur et/ou stabilisateur de cyclooxygenase d'au moins un derive de pyrimidine substitue en 6
IT1318379B1 (it) * 2000-03-08 2003-08-25 Ira Srl Composizione cosmetica o farmaceutica utile per inibire o ritardarel'alopecia umana mediante applicazione topica della composizione.

Also Published As

Publication number Publication date
ITMI20030369A1 (it) 2004-09-01
US6953571B2 (en) 2005-10-11
US20040197887A1 (en) 2004-10-07
ATE464063T1 (de) 2010-04-15
EP1454633A1 (de) 2004-09-08
ES2341855T3 (es) 2010-06-29
EP1454633B1 (de) 2010-04-14

Similar Documents

Publication Publication Date Title
GB0225474D0 (en) Therapeutic agents
GB0223038D0 (en) Therapeutic compounds
ATE214609T1 (de) Pharmazeutische zusammensetzungen zur behandlung von leberkrankheiten
ATE361084T1 (de) Topische pharmazeutische zusammensetzungen mit proanthocyanidinen, glycyrrhetinic säure und telmesteine zur behandlung von dermatitis
EE200100405A (et) 3-hüdroksü-3-metüülglutarüüli koensüümi kasutamine reduktaasi inhibiitorina ravimi valmistamiseks diabeetilise neuropaatia raviks
GB0005251D0 (en) Therapeutic compounds
HK1079446A1 (en) Pharmeceutical solid dispersions of modafinil compounds
AU2003295773A8 (en) Treatment of liver disease with active vitamin d compounds
CY1110061T1 (el) Συνθεσεις περιλαμβανοντας ενωσεις μοδαφινιλης
MY138883A (en) Use of asiatic acid for treatment of cencer
BR0316458A (pt) Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto
HK1099918A1 (en) Composition and use for prevention or treatment of stomatitis
ATE478662T1 (de) Arzneilösungen enthaltend modafinilverbindungen
AU2001262401A1 (en) Use of ellagic acid as anti-pollution cosmetic agent
SG153661A1 (en) Formulation and methods for the treatment of thrombocythemia
WO2006058298A3 (en) A method of administering anti-angiogenic agents and a method of treating disease using same
ATE340570T1 (de) 3,5,3'-triiodothyronin sulfat als thyromimetischer wirkstoff and pharmaceutische formulatierungen davon
AR036321A1 (es) Metodo y formulacion farmaceutica para el tratamiento de la discinesia de aparicion tardia.
AU2003238046A1 (en) Substituted 3- and 4- aminomethylpiperidines for use as beta-secretase in the treatment of alzheimer's disease
DE602004026499D1 (de) Topisch applizierbare kosmetische oder pharmazeutische Zusammensetzung zur Prävention oder Behandlung androgener Alopezie
ATE252383T1 (de) Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
BR0313230A (pt) Uso de carboxamidas para o tratamento de tinido
AU2003272189A1 (en) Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents
NL1022442C2 (nl) Toepassing van lipide ter verbetring van de opname van nutrienten en (farmaceutisch) actieve stoffen.
AR027958A1 (es) Composicion para la prevencion y/o tratamiento de enfermedades vasculares, que comprende propionil l-carnitina y coenzima q10

Legal Events

Date Code Title Description
8364 No opposition during term of opposition